Results of a Double-Blind Placebo-Controlled Study of 3,4-Diaminopyridine (DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS)
Publication
, Conference
Sanders, DB; Juel, VC; Harati, Y; Smith, AG; Peltier, A; Marburger, T; Lou, J-S; Pascuzzi, RM; Richman, DP; Xie, T; Ales, LRJKL; Jacobus, DP
Published in: ANNALS OF NEUROLOGY
October 1, 2015
Duke Scholars
Published In
ANNALS OF NEUROLOGY
EISSN
1531-8249
ISSN
0364-5134
Publication Date
October 1, 2015
Volume
78
Start / End Page
S104 / S104
Location
Chicago, IL
Publisher
WILEY-BLACKWELL
Conference Name
140th Annual Meeting of the American-Neurological-Association
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sanders, D. B., Juel, V. C., Harati, Y., Smith, A. G., Peltier, A., Marburger, T., … Jacobus, D. P. (2015). Results of a Double-Blind Placebo-Controlled Study of 3,4-Diaminopyridine (DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS). In ANNALS OF NEUROLOGY (Vol. 78, pp. S104–S104). Chicago, IL: WILEY-BLACKWELL.
Sanders, Donald B., Vern C. Juel, Yadollah Harati, A. G. Smith, Amanda Peltier, Tessa Marburger, Jau-Shin Lou, et al. “Results of a Double-Blind Placebo-Controlled Study of 3,4-Diaminopyridine (DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS).” In ANNALS OF NEUROLOGY, 78:S104–S104. WILEY-BLACKWELL, 2015.
Sanders DB, Juel VC, Harati Y, Smith AG, Peltier A, Marburger T, et al. Results of a Double-Blind Placebo-Controlled Study of 3,4-Diaminopyridine (DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS). In: ANNALS OF NEUROLOGY. WILEY-BLACKWELL; 2015. p. S104–S104.
Sanders, Donald B., et al. “Results of a Double-Blind Placebo-Controlled Study of 3,4-Diaminopyridine (DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS).” ANNALS OF NEUROLOGY, vol. 78, WILEY-BLACKWELL, 2015, pp. S104–S104.
Sanders DB, Juel VC, Harati Y, Smith AG, Peltier A, Marburger T, Lou J-S, Pascuzzi RM, Richman DP, Xie T, Ales LRJKL, Jacobus DP. Results of a Double-Blind Placebo-Controlled Study of 3,4-Diaminopyridine (DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS). ANNALS OF NEUROLOGY. WILEY-BLACKWELL; 2015. p. S104–S104.
Published In
ANNALS OF NEUROLOGY
EISSN
1531-8249
ISSN
0364-5134
Publication Date
October 1, 2015
Volume
78
Start / End Page
S104 / S104
Location
Chicago, IL
Publisher
WILEY-BLACKWELL
Conference Name
140th Annual Meeting of the American-Neurological-Association
Related Subject Headings
- Neurology & Neurosurgery
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences